TCL-6 Activators
The TCL-6 activators represent a diverse array of chemical compounds that exert their influence on TCL-6 activation through intricate cellular signaling pathways. One prominent group includes inhibitors of Wnt signaling, such as Pyrvinium Pamoate and LGK-974. Pyrvinium Pamoate antagonizes the Wnt pathway, leading to the upregulation of negative regulators that modulate TCL-6 expression and activity within the cellular context. Similarly, LGK-974 disrupts Wnt secretion, resulting in the activation of TCL-6 through the modulation of downstream effectors. Another class involves compounds like SB-431542 and PNU-74654, which indirectly activate TCL-6 by targeting TGF-β and Hedgehog signaling pathways, respectively. SB-431542, a selective inhibitor of TGF-β type I receptor, modulates downstream effectors, contributing to TCL-6 activation. PNU-74654, on the other hand, enhances Hedgehog signaling, positively regulating TCL-6 expression and activity in the cellular environment.
The GSK-3 inhibitors, BML-281 and CHIR-99021, also play a crucial role in TCL-6 activation. BML-281 modulates the Wnt pathway by inhibiting GSK-3, leading to altered TCL-6 expression. Similarly, CHIR-99021 influences TCL-6 activation through GSK-3 inhibition, affecting the Wnt pathway and contributing to TCL-6 activity within the cellular signaling network. These TCL-6 activators showcase the intricate interplay between chemical compounds and cellular pathways, providing valuable tools for researchers aiming to understand and modulate TCL-6 activity in diverse cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Pyrvinium Pamoate activates TCL-6 indirectly by inhibiting Wnt signaling. It antagonizes the Wnt pathway, leading to the upregulation of negative regulators that modulate TCL-6 expression and activity within the cellular context. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 influences TCL-6 activation through TGF-β signaling. As a selective inhibitor of TGF-β type I receptor, it modulates downstream effectors, affecting the cellular milieu and, subsequently, contributing to TCL-6 activation indirectly. | ||||||
PNU-74654 | 113906-27-7 | sc-258020 sc-258020A | 5 mg 25 mg | $131.00 $495.00 | 7 | |
PNU-74654 acts as an activator of TCL-6 by targeting the Hedgehog signaling pathway. It enhances Hedgehog signaling, resulting in downstream events that positively regulate TCL-6 expression and activity in the cellular environment. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 serves as an indirect activator of TCL-6 through the inhibition of Src family kinases. By disrupting Src-dependent signaling cascades, it influences cellular processes that converge on TCL-6, leading to its activation in a context-dependent manner. | ||||||
SC514 | 354812-17-2 | sc-205504 sc-205504A | 5 mg 10 mg | $67.00 $91.00 | 13 | |
SC-514 influences TCL-6 activation indirectly by inhibiting IKK-2. By disrupting the NF-κB pathway through IKK-2 inhibition, it modulates the cellular environment, contributing to the activation of TCL-6 in a context-dependent manner. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 acts as an indirect activator of TCL-6 by inhibiting PI3K. Through PI3K inhibition, it modulates downstream effectors, affecting the cellular milieu and, subsequently, contributing to TCL-6 activation in a context-dependent manner. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide indirectly activates TCL-6 by inhibiting the STAT3 signaling pathway. It disrupts STAT3-dependent events, leading to altered TCL-6 expression and activity within the cellular context. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK-974 activates TCL-6 indirectly by inhibiting Wnt secretion. It disrupts Wnt signaling, resulting in the upregulation of negative regulators that modulate TCL-6 expression and activity within the cellular context. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 serves as an indirect activator of TCL-6 by inhibiting NEDD8-activating enzyme. Through this inhibition, it modulates cullin-RING ligases, affecting the cellular environment and contributing to TCL-6 activation in a context-dependent manner. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR-99021 acts as an indirect activator of TCL-6 by inhibiting GSK-3. Through GSK-3 inhibition, it modulates the Wnt pathway, resulting in altered TCL-6 expression and activity within the cellular signaling network. | ||||||